Commercialization: Page 116
-
PharmaVoice Team/PharmaVoice
PharmaTrax
Drug Importation Poses Risks A federal HHS Task Force has warned in its Report on Prescription Drug Importation against the public health risks and economic effects of legalizing the importation of drugs from Canada and other countries with price controls. “This study confirms the deep flaws inhe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Pharma’s Clouds Aren’t Darkening the Employee Recruitment Outlook Contributed by Julie B. Kampf Massive product safety recalls; costly accounting and pricing violations; embarrassing marketing and sales transgressions — is the beleaguered pharmaceutical sector an executive recruiter’s nightmare? ...
By Julie B. Kampf • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single branding elements. Cr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
On the Calendar April 17-19 Medical Manufacturing Summit The Homestead Resort, Hot Springs, Va. For more information, contact Caria Badenhorst, Marcus Evans, at 246-417-5321, e-mail [email protected], or visit medicalmanufacturingsummit.com. April 18-19 Neurodegeneration in Alzheimer’s, Pa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Alan Colowick Threshold Pharmaceuticals Appoints Chief Medical Officer Threshold Pharmaceuticals has named Alan Colowick, M.D., chief medical officer. Threshold Pharmaceuticals, Redwood City, Calif., is focused on the discovery, development, and commercialization of small-molecule...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The PC Approach to Improving the Detail
The Tablet PC is starting to gain more traction in the pharmaceutical industry, particularly as a tool for sales reps during a detail. While concerns over price, size, and user-friendliness remain, industry experts predict their use will continue to increase.ime is not on their side. Pharmaceutic...
By Lisa Dress • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Relationship building As a veteran public-relations professional, long-time volunteer, and current member of the American Cancer Society (ACS), Eastern Division Board, serving New York and New Jersey, I would like to comment on Roger Sullivan’s letter (published in October 2004) in response to th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on your mind opinions Preferred-provider status Increasingly, companies that provide services to the life-sciences industry are required to be on a preferred provider list. In the November issue of PharmaVOICE, we asked are innovative/new ideas being overlooked in some cases because a serv...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
December 2003 Contents 8 Cyndi Verst-Brasch says Phase IV trials have to withstand regulatory vigor. 20 Pharma is becoming more involved in choosing investigator sites, says Mark Eisenach. 32 For Dr. John Patton, the life sciences are awe inspiring. on the cover The value of Phase IV Postmarketin...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies DVC Healthcare Launches Relationship- Marketing Practice DVC HealthCare, a division of DVC Worldwide, has expanded its service offerings to include a comprehensive relationship-marketing solution. The tool expands DVC’s ability to focus on ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
letter from the editor Phase IV studies can help differentiate a product from its competitors, medically support marketing objectives and messages, develop and enhance relationships with clinical investigators and key opinion leaders, increase physician exposure to a new drug, answer scientific q...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
The use of humor in pharmaceutical advertising, whether it is a professional or direct-to-consumer campaign, requires a delicate balance. But if done properly and with sensitivity, a light-hearted approach can separate the generic from the exceptional. Ted Whitby, senior VP and creative director ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCase
Making a case for transformational product marketing Lena Chow Lena Chow, founder of Lena Chow Advertising, and former chairman, chief strategic officer of Euro RSCG Life, discusses the challenges of implementing successful marketing campaigns for transformational products. A New Generation of He...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Today the pharmaceutical industry faces the challenge of deploying products in an increasingly competitive and cut-throat environment. As a result, there is enormous pressure to achieve maximum return on investment before patents expire. In addition, as patents on mega-blockbusters expire, the ph...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
December 2003 The forum for the industry executive PHASE IV TRIALS Balancing marketing and science adventuring forth with John Patton Marketing to nps and pas Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
NPs and PAs: A Growing Sphere of Influence
By Elisabeth Pena Sales reps are coming to us and providing us with good educational information, as well as the latest research data. Mary Kay Tucker The number of nurse practitioners and physician assistants empowered with the authority to prescribe medication is increasing annually. Addressing...
By Elisabeth Pena • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
John Patton: A Lifetime of Adventure
by Kim Ribbink A Lifetime of Adventure With a number of ground- breaking technologies under its belt, Nektar Therapeutics is vying to be the No. 1 drug-delivery company in the world. And the company’s cofounder and chief scientific officer, John Patton, Ph.D., has led the push to unearth solution...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New electronic and web-based applications, sites, and technologies Solutions From PHT Provide Clinical Trial Savings and Flexibility Two recently launched offerings from PHT Corp., LogPad Phone and the Technology Transfer Program, aim to make the electronic capture of clinical-trial information e...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, Marketing, And R&D Trends Affecting the Healthcare Industry Doctors Prefer Details by Specialty Reps In the past three years, specialty sales representatives have become an increasingly important promotional investment for pharmaceutical companies, according to Verispanís l...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
What can you say about a nearly 12-year-old brand that has less then half the share of the category leader and is indicated for a condition that even those who have been diagnosed have trouble paying attention to? The brand is Zocor, the asymptomatic condition is hypercholesterolemia, and the ans...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Dorothy Smith: Education, the Best Medicine
education, the best medicine Dr. Dorothy Smith has devoted her career to consumer healthcare education. She began by shaking up the role of the pharmacist by pushing for patient-counseling programs. Today, she continues to work tirelessly to ensure that consumers are informed and involved in deci...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Diagnostics and Devices: A Different Arena
Diagnostics and Devices different arena By Elisabeth Pena With smaller marketing budgets and a more focused, cost-conscious audience, the device and diagnostic sectors face challenges that require different strategies from their pharmaceutical counterparts. A number of world events bode well for ...
By Elisabeth Pena • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Data Strategy: Cracking the Marketing Code
Data Strategy Cracking the Marketing Code The creation of relevant marketing messages often relies on data that have been appropriately aggregated and analyzed. A well-conceived and implemented data strategy provides for a more targeted approach that ensures better results and increases return on...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Paul Harris Creating Memorable Visual Branding This past year, the pages of this publication and others in the pharmaceutical advertising niche have explored at length the matter of creativity in pharmaceutical ads. Theyíve addressed such questions as: Why aren’t pharma ads more cr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s new New healthcare-related products, services, and companies The HBA – A National Brand The Healthcare Businesswomenís Association has undergone a reorganization and created a new Northeast Corridor Metro Chapter to better serve its members. The Healthcare Businesswomen’s Association (HBA)...
By PharmaVoice Team • Jan. 2, 2008
Previous
